When Maya Chen started her period at thirteen, she knew something was wrong. The pain was different from what her friends described. It pulled her out of class, doubled her over on the bathroom floor, and left her missing school days month after month. She told doctors. She told teachers. She was told it was normal.
Twenty-three years later, after seeing doctors in three countries and consulting seven physicians, Maya received a diagnosis: endometriosis. The tissue that should only line her uterus had been growing outside it, causing inflammation, scarring, and agony she had been trying to describe for more than two decades.
Her story is not exceptional. It is barely unusual. Across the world, women and girls living with endometriosis wait an average of nearly seven years for a diagnosis. In the United Kingdom, that number stretches to nine years. Some women spend more than two decades not knowing why their bodies hurt so much. This is the diagnostic reality for a condition that affects roughly 190 million women globally, one in ten women of reproductive age.
Why the Body Makes Diagnosis So Difficult
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, most commonly on the ovaries, fallopian tubes, and pelvic lining. This tissue responds to hormonal cycles just as the uterine lining does, bleeding and swelling each month. Unlike blood that exits the body during menstruation, this detached blood has nowhere to go. It irritates surrounding tissue, causes inflammation, and gradually forms scar tissue and adhesions that can fuse organs together.
The problem is that this process happens inside the body. There is no external wound to see, no obvious marker to measure. Symptoms vary wildly from person to person. Some women experience debilitating pain with every cycle. Others have minimal discomfort but discover the disease only when they struggle to conceive. Many fall somewhere between these poles, their symptoms dismissed as ordinary menstrual pain or labelled as stress, anxiety, or overreacting.
The gold standard for confirming endometriosis has long been laparoscopy, a surgical procedure where a camera is inserted through a small incision in the abdomen. This invasive approach is why many women postpone seeking answers. Not every physician recommends it; not every patient can access it. Without visual confirmation, diagnosis often stalls.
We also lack a reliable biomarker. Unlike conditions where a blood test can confirm disease activity, endometriosis has resisted simple diagnostic tools for decades. The cellular changes are internal, variable, and often not visible on standard imaging unless the disease has progressed significantly. Research from Yale published in January 2026 identified microRNA biomarkers that may enable detection via a simple blood test, which could transform diagnostic pathways if validated and made widely available [3]. Until such tools reach clinical practice, physicians must rely heavily on patient-reported symptoms, which introduces subjectivity and bias.
The Normalisation of Pain
The delay is not purely biological. It is deeply cultural. Menstrual pain has been normalised, minimised, and mythologised for generations. Women are taught to expect suffering as part of womanhood. "Push through it," they are told. "It's part of being a woman." Girls who report severe pain are often reassured rather than evaluated. When they advocate for themselves repeatedly, they risk being labelled as anxious or difficult patients.
Research from the University of York, published in February 2024, examined twenty-two existing studies on diagnostic delays and found that lack of knowledge among both patients and health professionals compounds the problem [1]. Women struggle to articulate what they are experiencing. Medical records are often inadequate. And because symptoms vary and can mimic other conditions, physicians frequently pursue other explanations before considering endometriosis.
Stigma plays a role too. Pelvic pain is intimate. Discussing it requires courage, and many women withdraw from medical conversations rather than push against barriers. Some fear being judged. Others have encountered providers who seem uncomfortable with gynaecological complaints. The shame surrounding menstrual health keeps women silent and delays their care.
The consequences extend beyond pain. Between twenty-five and fifty percent of women with infertility have endometriosis [2]. For women who wanted children, the delay may have cost them years of reproductive time. Early diagnosis matters not only for symptom management but for protecting fertility. When endometriosis goes unrecognised for years, scarring can progress, making conception harder even with treatment.
A Landmark Change in Clinical Thinking
February 2026 brought a shift in how the medical establishment approaches diagnosis. The American College of Obstetricians and Gynecologists published its first-ever comprehensive clinical guidance on endometriosis, aiming to shorten the time to diagnosis and improve access to care [4].
The guidance explicitly recommends presumptive clinical diagnosis without requiring surgical confirmation. This means physicians can diagnose endometriosis based on symptoms and physical findings alone, treating patients earlier rather than waiting for laparoscopic proof. The guidance also addresses racial bias and gender-identity bias as additional barriers, acknowledging that Black women, transgender men, and non-binary individuals often face compounded delays in receiving appropriate care.
This shift matters because it changes the relationship between patients and providers. Women no longer need to undergo invasive surgery to have their pain acknowledged and treated. They can receive a diagnosis, start management strategies, and make informed decisions about their health without years of waiting.
What Science Is Getting Closer To
The Yale research on microRNA biomarkers represents the kind of diagnostic innovation the field desperately needs. By identifying specific molecules in the blood that correlate with endometriosis activity, scientists may soon offer a simple, non-invasive test that could replace or supplement surgical diagnosis [3]. For adolescents, in particular, a blood test could spare young girls from invasive procedures and enable treatment before the disease progresses.
Researchers in reproductive immunology are also exploring connections between endometriosis and immune system dysregulation. The World Health Organization notes emerging evidence that endometriosis may involve immune dysfunction alongside hormonal and structural factors [2]. Understanding this could open new therapeutic avenues beyond symptom management.
New symptom checklists and self-testing approaches are also being developed. Saliva tests and menstrual blood self-tests are under investigation as patient-controlled diagnostic tools. These innovations could democratise diagnosis, allowing women in underserved areas or those who face cultural barriers to clinical examination to gather data that supports their case with providers.
Listening Earlier, Diagnosing Sooner
Maya Chen eventually found a physician who believed her. She had surgery, started hormone therapy, and began rebuilding a life that had been organised around pain management. She was lucky. Most women are not.
The average delay of nearly seven years worldwide, four to twelve years according to the World Health Organization, is not a clinical inevitability. It is a consequence of knowledge gaps, cultural attitudes, and diagnostic limitations that we now have tools to address.
Listening to adolescents when they first report symptoms could shorten diagnosis from fourteen years to something far shorter. Expanding physician education, particularly in primary care settings where most women first seek help, could reduce the years spent navigating specialists who do not connect the dots. New biomarkers, if they prove reliable and accessible, could eliminate the need for surgical diagnosis altogether.
Endometriosis does not have a cure yet. But for the millions of women living with it, earlier diagnosis would be transformative. Better tools exist now than did a decade ago. Better guidelines exist. What remains is the will to implement them.